BIOMAT Database Logo BIOMAT Database Logo

Primary care treatment of depression in the elderly: a double-blind, multi-centre study of flupenthixol ('Fluanxol') and sustained-release amitriptyline. 1989

H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti

A multi-centre general practice study was carried out to compare flupenthixol and a sustained-release preparation of amitriptyline in the primary care treatment of depression in the elderly. Fifty-one clinically depressed patients, aged 65 years or over, were allocated at random to one of the two treatment groups in this 4-week double-blind, double-dummy study. On entry, patients received either a 0.5 mg flupenthixol tablet in the morning and a placebo capsule at night (25 patients) or a 25 mg sustained-release amitriptyline capsule at night and a placebo tablet in the morning (26 patients), but at the end of the first or second weeks the dosage could be doubled according to the assessed clinical need. Fourteen patients in each treatment group had their dosages doubled. Patient assessment was undertaken on study entry and after 1, 2 and 4 weeks of treatment using a 0 to 3 scale global assessment and the Montgomery Asberg Depression Rating Scale; side-effects were recorded on the UKU Scale. After 4-weeks' treatment, over 80% of patients in each group had improved and in the flupenthixol group there was additionally a noticeable and highly significant reduction in symptom severity after only 1 week of treatment. Patients treated with flupenthixol had fewer and milder side-effects.

UI MeSH Term Description Entries
D008297 Male Males
D011320 Primary Health Care Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (JAMA 1995;273(3):192) Primary Care,Primary Healthcare,Care, Primary,Care, Primary Health,Health Care, Primary,Healthcare, Primary
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005475 Flupenthixol A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. (From Martindale, The Extra Pharmacopoeia, 30th ed, p595) Emergil,Fluanxol,Flupentixol,alpha-Flupenthixol,cis-Flupenthixol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
A double-blind study of flupenthixol ('Fluanxol') in general practice.
January 1976, Current medical research and opinion,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
Nomifensine and amitriptyline in the treatment of depression. A multi-centre double-blind comparison.
September 1983, Acta psychiatrica Scandinavica,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
[Multicenter double-blind clinical trial with flupenthixol (Fluanxol) and flupenthixol+melitracen (Lu 6722) in the treatment of neuroses].
January 1973, Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
Treatment of depression in general parctice: a controlled trial of flupenthixol ('Fluanxol').
January 1974, Current medical research and opinion,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
[Treatment of depression in general practice. A controlled trial of flupenthixol (Fluanxol)].
July 1973, Ugeskrift for laeger,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
[Tryptophan and amitriptyline in the treatment of depression (double blind study)].
January 1973, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
[Tryptophan and amitriptyline in the treatment of depression (double blind study)].
January 1973, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
Flupenthixol versus diazepam in the treatment of psychosomatic disorders: a double-blind, multi-centre trial in general practice.
January 1984, Pharmatherapeutica,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
January 1988, Pharmatherapeutica,
H J Høstmaelingen, and O Asskilt, and S G Austad, and J Fjellheim, and E A Høstmaelingen, and P H Kristiansen, and T I Olsen, and T Skotte, and E Ofsti
Doxepin versus amitriptyline in depression: a sequential double-blind study.
May 1974, Current therapeutic research, clinical and experimental,
Copied contents to your clipboard!